NCT02743182View on ClinicalTrials.gov

HBsAg Loss Adding Pegylated Interferon in HBeAg-negative Patients

NACompletedINTERVENTIONAL
Enrollment

119

Participants

Timeline

Start Date

January 31, 2015

Primary Completion Date

October 31, 2018

Study Completion Date

November 30, 2018

Conditions
Chronic Hepatitis B (HBeAg-negative)
Interventions
DRUG

Pegylated interferon alfa-2a

All Listed Sponsors
collaborator

Instituto de Salud Carlos III

OTHER_GOV

lead

José Antonio Carrion

OTHER

NCT02743182 - HBsAg Loss Adding Pegylated Interferon in HBeAg-negative Patients | Biotech Hunter | Biotech Hunter